<DOC>
	<DOCNO>NCT00315003</DOCNO>
	<brief_summary>This multinational , randomize ( 1:1 ) , double-blind , double-dummy , comparative , 2- treatmentgroup study child ( age range : ≥6 month &lt; 72 month [ &lt; 6 year age ] ) AOM.Subjects randomize receive either telithromycin ( 50 mg/mL ) oral suspension 25 mg/kgonce daily 5 day azithromycin ( 40 mg/mL ) oral suspension ( 10 mg/kg Day 1 , follow 5 mg/kg daily Days 2-5 , exceed 500 mg onDay 1 250 mg/day Days 2 - 5 . Matching placebo suspension telithromycin azithromycin also dispense provide blind different treatment regimens.Assessments report safety carry visit .</brief_summary>
	<brief_title>TELI COM - Telithromycin Children With Otitis Media</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Suppuration</mesh_term>
	<mesh_term>Otitis Media , Suppurative</mesh_term>
	<mesh_term>Telithromycin</mesh_term>
	<criteria>Subjects meet follow criterion consider enrollment study : Subjects ≥6 month &lt; 72 month ( &lt; 6 year ) age ; Recent ( within last 72 hour ) rapid onset AOM symptom sign ; The presence MEF otoscopy indicate bulge tympanic membrane ; Otalgia ear tug touch within last 24 hour interfere precludes normal activity sleep ; At least 1 follow clinical finding specific AOM : fever , vomit , diarrhea , anorexia , sleep disturbance , irritability ; Caregiverreported AOM symptom sufficient entry accord protocol criterion . Caregiverreported AOM symptom diary Tympanometry exhibiting : Type B curve positive pressure peak curve . Subjects present follow include study : Uncertain diagnosis AOM mild moderate symptom sign AOM would make subject candidate observation analgesic therapy observation 23 day . Otorrhea tympanostomy tube present ear evaluate ; Otitis externa ; Down syndrome , cleft palate , craniofacial disorder , cystic fibrosis/mucoviscidosis , immotile cilium syndrome , congenital immunodeficiency acquire immunodeficiency syndrome &lt; 25 % CD4 count require prophylaxis Pneumocystis jiroveci ( carinii ) require treatment opportunistic infection ; Known congenital long QT syndrome ; Known suspect uncorrected hypokalemia ( ≤3 mmol/L [ mEq/L ] ) , hypomagnesemia , bradycardia ( &lt; 50 bpm ) ; Myasthenia gravis ; Known impair renal function , show creatinine clearance ≤25 mL/min ; History hypersensitivity intolerance macrolides azithromycin ; Previous enrollment study previous treatment telithromycin ; Children investigator subinvestigator , research assistant , pharmacist , study coordinator , staff , relative thereof directly involve conduct protocol .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Otitis Media</keyword>
	<keyword>Suppurative</keyword>
	<keyword>Purulent</keyword>
	<keyword>Ketolide</keyword>
	<keyword>Azithromycin</keyword>
	<keyword>Telithromycin</keyword>
	<keyword>Controlled Clinical Trials</keyword>
</DOC>